Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-17

FDA Approved: OXALIPLATIN — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approves Accord Healthcare Inc.'s supplemental application for Oxaliplatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)